These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 27355365)

  • 1. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
    Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T
    PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
    Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
    Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.
    Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B
    Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA; McRae JL; Dwyer KM
    Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
    Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.
    Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH
    Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating antibodies to α-enolase and phospholipase A
    Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
    Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy.
    Akiyama S; Akiyama M; Imai E; Ozaki T; Matsuo S; Maruyama S
    Clin Exp Nephrol; 2015 Aug; 19(4):653-60. PubMed ID: 25412738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X; Wen S; Zhu X; Yuan S; Xu X; Yang D; Sun L; Liu H; Liu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr; 42(4):395-399. PubMed ID: 28490696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.
    Kaga H; Komatsuda A; Yamamoto S; Kikuchi T; Kamata M; Sato A; Odaka M; Yokota SI; Takahashi N; Wakui H
    Clin Exp Nephrol; 2019 Apr; 23(4):465-473. PubMed ID: 30756249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.
    Zhang QH; Wu M; Hu ZG; Liu XB; Huang B; Zhang Y; Liu B; Zhu YS; Wang L; Sun ZX
    Biomed Res Int; 2020; 2020():1693710. PubMed ID: 32461964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment.
    Cheng G; Liu J; Gilbert A; Cao Y; An C; Lv Z; Wang C; Nie R; Zhang J; Liu Y; Xia M; Li S; Cai H; Li Y; Li Y; Qin X
    Clin Chim Acta; 2019 Mar; 490():135-141. PubMed ID: 30605630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy.
    Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
    Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
    Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C; Li L; Liu T; Qu X; Qiu Y
    Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
    Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
    PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.